Speaking of Science

» genomics, disease/medicine and evolution

Most Recent

image: Speaking of Science

Speaking of Science

By | July 1, 2015

July 2015's selection of notable quotes

5 Comments

image: Speaking of Vision Science

Speaking of Vision Science

By | October 1, 2014

October 2014's selection of notable quotes

1 Comment

image: Speaking of Science

Speaking of Science

By | September 1, 2014

September 2014's selection of notable quotes

0 Comments

image: Speaking of Science

Speaking of Science

By | April 1, 2014

April 2014's selection of notable quotes

2 Comments

image: Speaking of Science

Speaking of Science

By | March 1, 2014

March 2014's selection of notable quotes

2 Comments

image: Speaking of Science

Speaking of Science

By | January 1, 2014

January 2014's selection of notable quotes

0 Comments

image: Speaking of Science

Speaking of Science

By | September 1, 2013

September 2013's selection of notable quotes

1 Comment

image: Speaking of Science

Speaking of Science

By | May 1, 2013

May 2013's selection of notable quotes

3 Comments

image: Speaking of Science

Speaking of Science

By | December 1, 2012

December 2012's selection of notable quotes

0 Comments

image: Speaking of Science

Speaking of Science

By | October 1, 2012

October 2012's selection of notable quotes

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham